Free Shipping in the U.S. for orders over $1000.  Shop Now>>

MonoPolys

MonoPoly antibodies (MonoPolys™) are created by combining genetic material from different sources to produce a diverse array of antibodies engineered to target specific antigens. Unlike traditional monoclonal antibodies derived from a single parent cell, MonoPolys are generated from multiple cell lines, allowing these antibodies to simultaneously target multiple epitopes on a single antigen and enhancing their specificity and effectiveness.

These antibodies are crucial tools for diagnostics, as they can accurately detect and quantify specific disease-associated biomarkers. They are also used in therapeutic applications to treat cancer, autoimmune disorders, and infectious diseases. Additionally, the ability to tailor these antibodies for various applications makes them versatile assets in the fields of medicine and research.

NeoBiotechnologies utilizes advanced biotechnological methods to ensure a high degree of precision and control over the antibody production process, leading to consistent quality and reduced batch-to-batch variability.

Showing all 2 results

MonoPolys

Showing all 2 results

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK